IL263388B - Diproboks: a new and potent class of tlr agonists - Google Patents

Diproboks: a new and potent class of tlr agonists

Info

Publication number
IL263388B
IL263388B IL263388A IL26338818A IL263388B IL 263388 B IL263388 B IL 263388B IL 263388 A IL263388 A IL 263388A IL 26338818 A IL26338818 A IL 26338818A IL 263388 B IL263388 B IL 263388B
Authority
IL
Israel
Prior art keywords
diprovocims
new
tlr agonists
potent class
potent
Prior art date
Application number
IL263388A
Other languages
English (en)
Hebrew (he)
Other versions
IL263388A (en
Inventor
Bruce Beutler
Dale L Boger
Original Assignee
Univ Texas
Scripps Research Inst
Bruce Beutler
Dale L Boger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Scripps Research Inst, Bruce Beutler, Dale L Boger filed Critical Univ Texas
Publication of IL263388A publication Critical patent/IL263388A/en
Publication of IL263388B publication Critical patent/IL263388B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IL263388A 2016-06-29 2018-11-29 Diproboks: a new and potent class of tlr agonists IL263388B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662356314P 2016-06-29 2016-06-29
PCT/US2017/040028 WO2018005812A1 (en) 2016-06-29 2017-06-29 Diprovocims: a new and potent class of tlr agonists

Publications (2)

Publication Number Publication Date
IL263388A IL263388A (en) 2018-12-31
IL263388B true IL263388B (en) 2021-02-28

Family

ID=60787607

Family Applications (1)

Application Number Title Priority Date Filing Date
IL263388A IL263388B (en) 2016-06-29 2018-11-29 Diproboks: a new and potent class of tlr agonists

Country Status (10)

Country Link
US (1) US11040959B2 (https=)
EP (1) EP3445758B1 (https=)
JP (1) JP6964298B2 (https=)
KR (1) KR102522730B1 (https=)
CN (1) CN109641878B (https=)
AU (1) AU2017290238B2 (https=)
BR (1) BR112018077397A2 (https=)
CA (1) CA3026178C (https=)
IL (1) IL263388B (https=)
WO (1) WO2018005812A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164445A (zh) * 2018-08-02 2021-07-23 得克萨斯系统大学评议会 Tlr1/2激动剂地普罗考姆的佐剂作用协同增效检查点抑制性抗体以消除疾病
JP2023527792A (ja) 2020-05-27 2023-06-30 アキシャル セラピューティクス,インク. Tlr2調節剤化合物、医薬組成物、及びそれらの使用
US20250367166A1 (en) * 2022-04-29 2025-12-04 The Scripps Research Institute Next generation diprovocims that activate the innate and adaptive immune response
US20260091126A1 (en) * 2022-09-20 2026-04-02 The Curators Of The University Of Missouri Amino acid-modified lipids for rna delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1418905T3 (da) 2001-08-08 2007-09-10 Pentraxin Therapeutics Ltd Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma
WO2005016235A2 (en) * 2003-04-14 2005-02-24 The Regents Of The University Of California Combined use of impdh inhibitors with toll-like receptor agonists
PE20071079A1 (es) 2005-11-15 2007-12-16 Cytokinetics Inc Compuestos de piperidina como inhibidores de la proliferacion celular
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
EP2958889B1 (en) 2013-02-25 2017-03-22 The Scripps Research Institute Neoseptins: small molecule adjuvants
US9918959B2 (en) 2014-08-06 2018-03-20 The Board Of Regents Of The University Of Texas System TLR-independent small molecule adjuvants

Also Published As

Publication number Publication date
CN109641878B (zh) 2021-09-14
CA3026178C (en) 2024-05-21
WO2018005812A1 (en) 2018-01-04
KR20190014133A (ko) 2019-02-11
CA3026178A1 (en) 2018-01-04
IL263388A (en) 2018-12-31
JP6964298B2 (ja) 2021-11-10
EP3445758A1 (en) 2019-02-27
US11040959B2 (en) 2021-06-22
AU2017290238B2 (en) 2021-02-18
EP3445758A4 (en) 2019-09-25
BR112018077397A2 (pt) 2019-10-01
KR102522730B1 (ko) 2023-04-19
AU2017290238A1 (en) 2018-12-13
CN109641878A (zh) 2019-04-16
JP2019519574A (ja) 2019-07-11
EP3445758B1 (en) 2020-11-04
US20200207742A1 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
ZA201801750B (en) Farnesoid x receptor agonists and uses thereof
GB2554283B (en) Devices for simulating a function of a tissue and methods of use and manufacturing thereof
IL251293B (en) Operating a device with mechanical arms
GB201612290D0 (en) Methods of manufacturing a secuirty device
IL263028A (en) Formulation containing tlr agonist and methods of use
EP3091970A4 (en) Lxr agonists and uses thereof
NO20190232A1 (en) Determining characteristics of a fracture
GB201615074D0 (en) Wing tip device
IL263388B (en) Diproboks: a new and potent class of tlr agonists
IL264628A (en) Combination of fxr agonists
LT3217978T (lt) Kompozicijos, apimančios pakeistą benzofurochinoliziną ir alfa2-adrenerginius agonistus
GB201421381D0 (en) A nematicidal composition and the use thereof
GB2533082C (en) A nematicidal composition and the use thereof
GB2588276B (en) Devices for simulating a function of a tissue and methods of use and manufacturing thereof
GB201608864D0 (en) Wing tip device
PT3471835T (pt) Utilização de extratos de deschampsia antarctica para combater danos na barreira cutânea humana provocados por agressões ambientais
GB201414991D0 (en) A garment hanger and a spring for use therein
AU201716611S (en) a pair of pants
AU201716609S (en) a pair of pants
AU201716610S (en) a pair of pants
AU367314S (en) A pair of pants
AU201613556S (en) A pair of pants
GB201622143D0 (en) Modification of polypeptides
GB201605291D0 (en) Hand etc cuffs
GB2571646B (en) A nematicidal composition and the use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed